A new age of personalised treatment for prostate cancer

CORDIScovery – unearthing the hottest topics in EU science, research and innovation

CORDIScovery에서 제공하는 콘텐츠입니다. 에피소드, 그래픽, 팟캐스트 설명을 포함한 모든 팟캐스트 콘텐츠는 CORDIScovery 또는 해당 팟캐스트 플랫폼 파트너가 직접 업로드하고 제공합니다. 누군가가 귀하의 허락 없이 귀하의 저작물을 사용하고 있다고 생각되는 경우 여기에 설명된 절차를 따르실 수 있습니다 https://ko.player.fm/legal.

1+ y ago 30:05

MP3•에피소드 홈

Computational power, AI, genomics: the treatment and diagnosis of prostate cancer is advancing rapidly. This episode finds out how.

A leap forward in the diagnosis and treatment would be very welcome: prostate cancer is the second most frequent malignancy in men. In 2020 alone, around one and a half million new cases and almost half a million deaths were registered worldwide. To explore new diagnostics and treatment are:

Jan Tkac, founder and chief scientific officer at Glycanostics, in Slovakia. The company has developed an innovative diagnostic test for cancer, based on novel biomarkers. Jan is also keen to explore how different sports relate to the levels of endorphin release.

Harald Mischak, chief scientific officer of Mosaiques Diagnostics & Therapeutics, Germany. Harald is focused on understanding the underlying molecular structures of certain types of cancers.

Joaquin Mateo, group leader of the Prostate Cancer Translational Research Group at Vall d’Hebron Institute of Oncology, in Barcelona. He is especially interested in the development of novel forms of precision medicine.

For more info on the projects featured, visit: https://europa.eu/!dgTGkb

49 에피소드

#Science #CORDIScovery